Mental Health Pathfinders: GLP-1 Medications: What Psychiatrists Need to Know

Om avsnittet

GLP-1 medications are reshaping obesity care, but their potential impact may extend well beyond weight loss. In this episode of Mental Health Pathfinders, host Erin Connors speaks with Charles Nemeroff, M.D., about what psychiatrists should know about GLP-1 medications, from addressing weight gain and metabolic risks associated with psychiatric treatment to emerging research on cravings, alcohol use disorder, and other addictive behaviors. They also discuss potential psychiatric effects, safety considerations, and concerns about inappropriate use as these medications become increasingly common.

Om avsnittet

Fler avsnitt

Psychiatric News Special Report: Digital Hyperconnectivity: A New Psychiatric Framework

Más allá del idioma: cultura, representación y atención de salud mental

Women Psychiatrists Caucus Chats: Dr. Katherine Kennedy on Advocacy and Leadership in Psychiatry

Special Report: An Update on Treatments for Alzheimer's Disease

Mental Health Pathfinders: Mental Health After Disaster with Dr. Andrew McLean

Psychiatric News Special Report: Evidence-Based Management of Behavioral Symptoms of Dementia

Psychiatric News Special Report: Lithium Clinics and High-Risk Populations With Bipolar Disorder

Women Psychiatrists Caucus Chats: Dr. Theresa Miskimen Rivera on Leading with Purpose

Mental Health Pathfinders: What Psychiatrists Need to Know About AI with Dr. John Torous

Psychiatric News Special Report: Clinical Considerations of Cannabis Use in the Inpatient Medical Setting